Although a positive correlation between KRAS mutation and PD-L1 expression has been observed in lung and pancreatic cancer, PD-L1 expression has been associated with reduced frequency of KRAS mutation in CRC. This evidence concerns the gene CD274 and pancreatic neoplasm.